Plateau = switch is reasonable
For some, the discomfort becomes overwhelming at times
New insights into the structure and function of class B1 GPCRs
over 50% of patients achieved 20 to 25% weight reduction thresholds at 176 weeks Semaglutide 2.4 mg: Up to 13.9% weight loss at 68 weeks Liraglutide 3.0 mg: Approximately 5.8% weight loss at 26 weeks Retatrutide (investigational triple agonist): Up to 22.1% weight loss at 48 weeks A meta-analysis of 47 randomized controlled trials confirmed a mean weight reduction of 4.57 kg, BMI reduction of 2.07 kg/m2, and waist circumference reduction of 4.55 cm versus placebo across all GLP-1 receptor agonists
Effectiveness of GLP-1R agonists on weight loss in humans Despite not have a complete understanding of the underlying molecular mechanisms, GLP-1R activation clearly has beneficial effects on both energy and glucose metabolism across a number of species
Green tea, gymnema, turmeric, and B vitamins provide antioxidant and metabolic support